Alla Y. Zemlyak, MD Comparison of survival after sublobar resections and ablative therapies for stage I NSCLC Primary end points overall survival, cancer-specific survival, and cancer-free survival N=25 SLR N=12 RFA N=27 Cryo N= CECT, FDG...